Characteristics | National Graduate Survey 2016–2019 | Continuing Certification 2017–2019 | ||||
---|---|---|---|---|---|---|
ADM Certified | Not ADM Certified | P value* | ADM Certified | Not ADM Certified | P value* | |
n (%) | n (%) | n (%) | n (%) | |||
Prenatal care | † | 18 (12.9) | 2,805 (11.2) | .521 | ||
Delivering babies | 7 (14.9) | 1,194 (13.7) | .806 | 12 (8.6) | 1,637 (6.6) | .323 |
Newborn hospital care | 10 (21.3) | 2,101 (24.0) | .665 | 14 (10.1) | 3,169 (12.7) | .356 |
Pediatric hospital care (not newborn) | 8 (17.0) | 1,714 (19.6) | .661 | 8 (5.8) | 2,286 (9.1) | .166 |
Pediatric outpatient care | 28 (59.6) | 6,704 (76.5) | .006 | 43 (30.9) | 13,812 (55.3) | <.001 |
Adult inpatient medicine | 19 (40.4) | 3,445 (39.4) | .885 | 41 (29.5) | 6,079 (24.3) | .157 |
Intensive care/ICU-CCU | 8 (17.0) | 1,953 (22.3) | .386 | 11 (7.9) | 2,316 (9.3) | .583 |
Behavioral health care | 44 (93.6) | 7,693 (87.8) | .224 | 99 (71.2) | 8,962 (35.9) | <.001 |
Integrative medicine | 8 (17.0) | 1,648 (18.8) | .754 | 14 (10.1) | 1,132 (4.5) | .002 |
End of life care | 20 (42.6) | 5,354 (61.1) | .009 | 22 (15.8) | 7,071 (28.3) | .001 |
Buprenorphine treatment | 44 (93.6) | 886 (10.1) | <.001 | 26 (83.9) | 285 (5.7) | <.001‡ |
Pharmacologic management of HIV/AIDS | 15 (31.9) | 1,554 (17.8) | .012 | 1 (3.2) | 197 (3.9) | 1.000‡ |
Pharmacologic management of hepatitis C | 23 (48.9) | 1,688 (19.3) | <.001 | 6 (19.4) | 183 (3.6) | <.009† |
ABFM, American Board of Family Medicine; ADM, addiction medicine; HIV/AIDS, human immunodeficiency virus/acquired immuno deficiency syndrome; ICU-CCU, intensive care unit-coronary care unit.
↵* Unless otherwise noted, χ2 test was to calculate the P value.
↵† Data on prenatal care provision was not available for the National Graduate Survey.
↵‡ Fisher exact test was used to calculate this P value.